Innovative technologies for early disease detection and ongoing surveillance of high-risk individuals are vital components of prevention and treatment strategies. To bolster engagement with risk identification programs, it is essential to identify people with the potential to develop disease before the onset of clinical symptoms, which are often indicative of advanced disease. Artificial intelligence (AI) […]

Author